| Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up M Ducreux, AS Cuhna, C Caramella, A Hollebecque, P Burtin, D Goéré, ... Annals of oncology 26, v56-v68, 2015 | 1498 | 2015 |
| Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin D Elias, JH Lefevre, J Chevalier, A Brouquet, F Marchal, JM Classe, ... J Clin oncol 27 (5), 681-685, 2009 | 1017 | 2009 |
| Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre … F Quénet, D Elias, L Roca, D Goéré, L Ghouti, M Pocard, O Facy, ... The Lancet Oncology 22 (2), 256-266, 2021 | 485 | 2021 |
| Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer S Julien, A Merino-Trigo, L Lacroix, M Pocard, D Goéré, P Mariani, ... Clinical Cancer Research 18 (19), 5314-5328, 2012 | 387 | 2012 |
| A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7 F Quenet, D Elias, L Roca, D Goere, L Ghouti, M Pocard, O Facy, ... J Clin Oncol 36 (18 Suppl), 3503, 2018 | 375 | 2018 |
| Are G3 ENETS neuroendocrine neoplasms heterogeneous? FL Vélayoudom-Céphise, P Duvillard, L Foucan, J Hadoux, CN Chougnet, ... Endocrine-related cancer 20 (5), 649-657, 2013 | 367 | 2013 |
| Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? D Goéré, D Malka, D Tzanis, V Gava, V Boige, C Eveno, L Maggiori, ... Annals of surgery 257 (6), 1065-1071, 2013 | 268 | 2013 |
| Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis PE Bonnot, G Piessen, V Kepenekian, E Decullier, M Pocard, B Meunier, ... Journal of Clinical Oncology 37 (23), 2028-2040, 2019 | 263 | 2019 |
| Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis D Elias, C Honoré, F Dumont, M Ducreux, V Boige, D Malka, P Burtin, ... Annals of surgery 254 (2), 289-293, 2011 | 261 | 2011 |
| Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT C Dromain, S Leboulleux, A Auperin, D Goere, D Malka, J Lumbroso, ... Abdominal imaging 33, 87-93, 2008 | 237 | 2008 |
| Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure V Boige, D Malka, D Elias, M Castaing, T De Baere, D Goere, C Dromain, ... Annals of surgical oncology 15, 219-226, 2008 | 230 | 2008 |
| Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study D Goéré, A Souadka, M Faron, AS Cloutier, B Viana, C Honoré, F Dumont, ... Annals of surgical oncology 22, 2958-2964, 2015 | 228 | 2015 |
| Hepatic metastases from neuroendocrine tumors with a “thin slice” pathological examination: they are many more than you think… D Elias, JH Lefevre, P Duvillard, D Goéré, C Dromain, F Dumont, ... Annals of surgery 251 (2), 307-310, 2010 | 217 | 2010 |
| The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study M Messager, JH Lefevre, V Pichot-Delahaye, A Souadka, G Piessen, ... Annals of surgery 254 (5), 684-693, 2011 | 216 | 2011 |
| Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma D Goere, GD Wagholikar, P Pessaux, N Carrère, A Sibert, V Vilgrain, ... Surgical Endoscopy and Other Interventional Techniques 20, 721-725, 2006 | 200 | 2006 |
| Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases D Elias, D Goéré, F Dumont, C Honoré, P Dartigues, A Stoclin, D Malka, ... European journal of cancer 50 (2), 332-340, 2014 | 189 | 2014 |
| Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review C Honoré, D Goéré, A Souadka, F Dumont, D Elias Annals of surgical oncology 20, 183-192, 2013 | 187 | 2013 |
| Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal … F Quenet, D Goéré, SS Mehta, L Roca, F Dumont, M Hessissen, ... Annals of surgery 254 (2), 294-301, 2011 | 187 | 2011 |
| A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma … D Elias, O Glehen, M Pocard, F Quenet, D Goéré, C Arvieux, P Rat, F Gilly, ... Annals of surgery 251 (5), 896-901, 2010 | 183 | 2010 |
| Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis D Elias, D Goéré, D Di Pietrantonio, V Boige, D Malka, N Kohneh-Shahri, ... Annals of surgery 247 (3), 445-450, 2008 | 181 | 2008 |
